Corcept Therapeutics

Key Account Manager (KAM) - Germany

Corcept Therapeutics  •  Berlin, DE (Remote)  •  2 months ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.

Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.

Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com

We are seeking a Key Account Manager (KAM) – Oncology to support the launch and growth of Corcept’s oncology portfolio in Germany. This is a unique opportunity to join a pioneering organization as it expands its oncology presence in the European market. The Key Account Manager is responsible for driving awareness, adoption, and appropriate use of Corcept’s oncology products within assigned key accounts across Germany. The role focuses on strategic account management, stakeholder engagement, and compliant promotional activities to ensure optimal patient access in a complex healthcare environment.

Key Responsibilities

  • Develop and execute account based strategic plans tailored to the needs of oncologists, multidisciplinary care teams, hospital systems, and other relevant stakeholders
  • Achieve sales and performance objectives through high-quality, compliant interactions with healthcare professionals and key decision makers within oncology accounts
  • Provide accurate, balanced, and compliant information on product clinical data, safety profile, and appropriate patient selection
  • Collaborate closely with cross functional partners including Medical Affairs, Market Access, Marketing, and Commercial Operations to optimize account outcomes to ensure coordinated engagement with key accounts
  • Analyze local market dynamics, competitive landscape, treatment pathways, and access barriers to identify opportunities and risks
  • Ensure all activities are conducted in strict compliance with German pharmaceutical law, industry codes, and Corcept standards
  • Represent Corcept professionally at national and regional oncology congresses and scientific meetings in Germany
  • Contribute to a high performing, values driven culture through accountability, integrity, continuous development, and a patient first mindset

Preferred Qualifications & Experience

  • Fluency in English (written and spoken) is required, including the ability to communicate effectively with colleagues in other geographies
  • Bachelor’s degree in Life Sciences, Business, or a related field
  • Minimum 10 years of pharmaceutical sales experience, including at least 5 years in oncology
  • Proven success managing complex hospital and specialist oncology accounts in Germany
  • Strong understanding of German oncology treatment guidelines, reimbursement mechanisms, and healthcare system dynamics
  • Demonstrated ability to develop and execute strategic account plans in a competitive environment
  • High level of business acumen, analytical capability, and cross functional collaboration
  • Willingness to travel extensively within the assigned territory (approximately 50–75%)
  • Oncology product launch experience in Germany
  • Experience in gynecologic oncology, ovarian cancer, or related oncology subspecialties
  • Background in startup or growth stage pharmaceutical organizations
  • Established relationships with oncologists, cancer centers, and key opinion leaders within Germany

Legal & Professional Certifications (Germany)

To perform this role in Germany, candidates must meet the legal requirements for pharmaceutical field representatives, including:

  • Certification as a Pharmaceutical Sales Representative (Pharmareferent/in) in accordance with §75 of the German Medicines Act (Arzneimittelgesetz, AMG)
    • A recognized degree in pharmacy, medicine, chemistry, biology, or a related life‑science discipline or
    • Successful completion of the IHK Pharmareferent (IHK) certification or an equivalent recognized qualification
    • This may be fulfilled through:
  • Demonstrated knowledge of:
    • German pharmaceutical law (AMG)
    • HWG (Heilmittelwerbegesetz – German Drug Advertising Act)
    • Industry codes (e.g., FSA Code of Conduct)

#LI-Remote

Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.

Corcept Therapeutics

About Corcept Therapeutics

We’ve been unlocking the potential of cortisol modulation for more than 25 years.

We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

Industry
Biotech & Life Sciences
Company Size
501-1,000 employees
Headquarters
Redwood City, California
Year Founded
1998
Social Media